Roberts Brandi
SEC insider (Form 3/4/5 filer). CIK 0001516354. Chief Financial Officer at Definium Therapeutics, Inc. (DFTX) and 1 other issuer. 14 reported Form 4/5 transactions since Sep 2024; latest on Sep 25, 2026. Located in NEW YORK, NY.
Companies Roberts Brandi has filed insider reports for
- Definium Therapeutics, Inc. (DFTX): Officer, Chief Financial Officer
- Longboard Pharmaceuticals, Inc. (LBPH): Officer, Executive VP and CFO
Roberts Brandi
CIK: 0001516354
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Sep 25, 2026DFTX
Definium Therapeutics, Inc.
SaleDirect3.4K shares at avg. $36.57$123K - Sep 14, 2026DFTX
Definium Therapeutics, Inc.
AwardDirect125K shares- - Aug 12, 2026DFTX
Definium Therapeutics, Inc.
AwardDirect62.5K shares- - Jun 25, 2026DFTX
Definium Therapeutics, Inc.
SaleDirect3K shares at avg. $45.03$136K - Jun 22, 2026DFTX
Definium Therapeutics, Inc.
AwardDirect62.5K shares- - Feb 3, 2026DFTX
Definium Therapeutics, Inc.
AwardDirect150K shares- - Jun 2, 2025MNMD
Mind Medicine (MindMed) Inc.
AwardDirectStock Option (Right to Buy)
500K shares- - Dec 2, 2024LBPH
Longboard Pharmaceuticals, Inc.
DispositionDirectRestricted Stock Unit
7.9K shares- - Dec 2, 2024LBPH
Longboard Pharmaceuticals, Inc.
DispositionDirectEmployee Stock Option (right to buy)
139.4K shares- - Dec 2, 2024LBPH
Longboard Pharmaceuticals, Inc.
DispositionDirectEmployee Stock Option (right to buy)
90K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 25, 2026 |  DFTX Definium Therapeutics, Inc. | Sale | 3,377 | $36.57 | $123,497 | Direct |
| Sep 14, 2026 | DFTX Definium Therapeutics, Inc. | Award | 125,000 | - | $0 | Direct |
| Aug 12, 2026 | DFTX Definium Therapeutics, Inc. | Award | 62,500 | - | $0 | Direct |
| Jun 25, 2026 | DFTX Definium Therapeutics, Inc. | Sale | 3,013 | $45.03 | $135,675 | Direct |
| Jun 22, 2026 | DFTX Definium Therapeutics, Inc. | Award | 62,500 | - | $0 | Direct |
| Feb 3, 2026 | DFTX Definium Therapeutics, Inc. | Award | 150,000 | - | $0 | Direct |
| Jun 2, 2025 |  MNMD Mind Medicine (MindMed) Inc. | Award Stock Option (Right to Buy) | 500,000 | - | - | Direct |
| Dec 2, 2024 |  LBPH Longboard Pharmaceuticals, Inc. | Disposition Restricted Stock Unit | 7,900 | - | - | Direct |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | Disposition Employee Stock Option (right to buy) | 139,380 | - | - | Direct |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | Disposition Employee Stock Option (right to buy) | 90,000 | - | - | Direct |
1-10 of 14 transactions